The Endless Contract: CME vs. Kalshi and the Battle Over Whether a Future Can Last Forever

For nearly 160 years, the futures contract has had a horizon. You buy it, you hedge with it, you speculate on it, but the instrument always runs to a terminal date. Margining models, clearing house rules, position limits, bankruptcy waterfalls, investor protection frameworks — every layer of the regulatory architecture assumes that end point exists. On May 29, 2024, the Commodity Futures Trading Commission approved a product that quietly erased it.

Kalshi, a Washington-based prediction market operator best known for election and economic event contracts, received permission to list BTCPERP: a cash-settled bitcoin perpetual futures contract tethered to spot prices through a recurring funding rate, carrying no delivery month and no expiration. The innovation was not cryptographic. Crypto-native exchanges had run this exact mechanism for years. The innovation was jurisdictional. Kalshi had successfully compressed a decade of offshore perpetual swap design into the legal mold of a CFTC-regulated, onshore futures product.

CME Group, the incumbent titan of regulated bitcoin derivatives, responded the way incumbents respond when a genre boundary shifts: it sued. The exchange asked a federal court in the District of Columbia to declare that Kalshi's product is not a futures contract at all — because a contract without an expiration date is, in CME's telling, closer in kind to a swap. The CFTC moved to dismiss the complaint, arguing that CME's competitive anxieties were exaggerated and that the Chicago exchange was free to launch its own perpetual product if it believed demand existed.

This is not a dispute over technology. Unearthing the logic within the speculative fog: it is a dispute over genre classification, fought at the exact point where financial instruments become legal identities. And the outcome will determine whether perpetual-style contracts migrate from the offshore crypto fringe into the core of American institutional market infrastructure — or remain trapped in a regulatory gray zone for another decade.

The Legal Core: What Dies When a Contract Never Ends?

To understand why this litigation matters, look at the architecture of the traditional derivative. A futures contract is defined, in part, by its expiration. That date performs essential mechanical work: it obliges the convergence of futures price to the underlying spot price; it triggers final settlement; it creates a clean, observable event upon which clearinghouses can manage counterparty risk. Expiration is not a formality. It is the spine of the futures legal structure.

Perpetual contracts dispense with that spine. Instead of a legally mandated expiry event forcing price convergence, they rely on a funding rate — a periodic cash payment between long and short positions that creates an economic incentive for prices to track the underlying index. When the perpetual trades above spot, long positions pay short positions, discouraging further long accumulation and pulling price down. When it trades below spot, the payment reverses. Over time, the mechanism performs the same job as expiration, but through market incentives rather than legal compulsion.

That distinction is the legal fulcrum of CME's complaint. CME argues that removing the expiration date transforms the instrument's character. In a futures contract, the price-discovery mechanism culminates in delivery or cash settlement. In a perpetual, positions roll forward indefinitely, with cash flows exchanging on a continuous basis. CME says continuous cash flow is a hallmark of a swap — and if BTCPERP is truly a swap, it must comply with the Commodity Exchange Act's swap-specific regime: swap execution facility trading, real-time public reporting, reconciliation requirements, and a different clearing and margining pipeline.

Decoding the signal from the narrative noise, however, reveals that CME's argument is less about the product's technical structure than about who gets to control the financial genre. The perpetual is not genuinely novel. Its mechanism was battle-tested in the most adversarial market conditions imaginable — BitMEX's 2016 launch, the March 2020 crash, the November 2022 FTX contagion. What is novel is the attempt to rebrand an offshore-native derivative as a Main Street futures contract without changing a single line of its economic logic.

From my own audit experience during 2020's DeFi summer, I learned that the funding rate is not merely a price-correcting device. It is an instrument of continuous consent. Traditional futures ask traders to make a single, time-bound bet. Perpetuals force every participant to revalidate their position every few hours, paying for the privilege of holding an opinion. That cadence of recurring monetary affirmation changes trader behavior in ways that regulatory classification cannot capture: positions are smaller, time horizons shorter, and the price discovery process runs like a heartbeat rather than a pulse.

Positioning the Product: Structural Innovation, Not Technological Breakthrough

Analysts often conflate product innovation with technological innovation. Kalshi's BTCPERP is not a breakthrough in code, consensus, or cryptography. It is a breakthrough in packaging. It takes a derivative design largely confined to offshore crypto exchanges, strips away the jurisdictional distance, and wraps it in the approval apparatus of the most established derivatives regulator in the world.

The product details matter. Per the approval, BTCPERP is cash-settled; there is no physical exchange of bitcoin. It tracks the spot market through the same funding rate architecture used by Binance, OKX, and other crypto-native exchanges. The structural novelty lies solely in the absence of expiration — and in the fact that the CFTC was willing to bless that absence within a futures framework.

What this means for the broader market is significant: if BTCPERP is allowed to stand as a futures product, then perpetual contracts generally — the largest single product genre in the offshore crypto derivative economy, with hundreds of billions in monthly notional volume — are conceptually portable into the US regulated market. If BTCPERP is instead reclassified as a swap, that migration path closes. Every offshore exchange watching this case understands the stakes: it is not about one contract on one venue, but about whether the entire product category receives a regulatory passport into the world's deepest institutional liquidity pool.

The CFTC's own filing makes the category-level stakes explicit. The agency told the court that CME faces no unique competitive injury because CME could launch its own perpetual product with a similar design. That statement, buried in legal argument, is effectively the CFTC acknowledging a new template: perpetual futures are a category the agency expects to see replicated. The commission is not defending one startup's product. It is defending its own power to define what a future is — and its implicit right to expand that definition to accommodate the mathematical descendants of an offshore derivative.

Why CME Filed Suit: The Volume Paradox

Conventional narrative frames CME's lawsuit as a defense of market share: the biggest regulated bitcoin derivatives venue protecting its turf against a nimble challenger. The available data complicates that story badly.

CME's own bitcoin futures volumes rose in June 2024 and again in August 2024 — both months after Kalshi's product received approval. If Kalshi's new perpetual was cannibalizing institutional order flow, the exchange's own volume data should have shown it. Instead, the incumbents volumes expanded in the precise period when the new product existed.

That dataset cuts differently. It suggests that the approval of a regulated perpetual may have drawn new attention, new interest, and new participants into the broader category of compliant bitcoin derivatives — benefiting CME's existing products alongside Kalshi's new one. The CFTC clearly noticed this. Its motion to dismiss highlights the fact that CME has not demonstrated a concrete, particularized injury. A competitor that is simultaneously growing its own trading volumes while suing a startup over a recent approval has a persuasiveness problem in court.

But viewing CME's lawsuit solely through the lens of current volume misses the deeper strategic incentive. Incumbents do not sue only over realized losses. They sue to shape the rules of future competition. If Kalshi's perpetual is confirmed as a futures product through regulatory approval alone — without formal rulemaking, without congressional input, without public industry comment — then the CFTC effectively possesses unilateral authority to spawn new tradable product genres by administrative fiat. That is a precedent CME cannot allow, because it means every future challenger can request product approval without the industry's largest players having a meaningful voice.

From an incentive-centric perspective, CME is not fighting the existence of perpetual contracts. It is fighting the process by which product categories are born. A court ruling that forces the CFTC to articulate why a no-expiration contract is a future — or to justify its classification framework through formal rulemaking — gives CME something far more valuable than a ban: a seat at the table when the category is defined. In financial markets, whoever controls the definition controls the competitive playing field.

The Loper Bright Shadow: Why the CFTC Is Running Scared, Strategically

There is an invisible force shaping the CFTC's aggressive motion to dismiss: the death of Chevron deference. In June 2024, the Supreme Court's decision in Loper Bright Enterprises v. Raimondo eliminated the longstanding principle that courts defer to federal agencies' reasonable interpretations of ambiguous statutes. That decision landed approximately three weeks before CME filed its lawsuit.

This timing is not incidental. For decades, the CFTC could approve a novel product structure with confidence that, if challenged, courts would grant broad deference to its statutory interpretation. A perpetual future approved as a 'future' would survive review because the CEA's ambiguity around the term allowed regulatory discretion. After Loper Bright, that safety net collapsed. Federal judges now interpret statutory language independently, without deferring to the agency's expertise.

This explains why the CFTC is litigating so defensively. It filed a motion to dismiss rather than simply defending the merits of its classification — a strategy aimed at preventing the court from ever reaching the interpretive question. If the court grants the motion, the CFTC's approval authority remains untested and intact. If the case proceeds to summary judgment or trial, the agency risks a precedential ruling that curtails its interpretive power — not merely for this product, but for every future innovation the CEA did not explicitly anticipate.

The Real Stakes of a Swap Classification

Market participants may assume that reclassifying BTCPERP as a swap would produce only a cosmetic change — that Kalshi could relabel its product, continue trading, and the industry would barely notice. This assumption is dangerously incomplete.

The classification of a derivative shapes its operational plumbing. A futures contract on a designated contract market operates under one set of rules: central clearing through a derivatives clearing organization, standardized margin, daily settlement, and a clear position ownership chain. A swap operates under a different infrastructure entirely: trade execution on a swap execution facility, real-time transaction reporting, portfolio reconciliation under CFTC Regulation 23, and margin rules that differ for financial and non-financial counterparties.

If BTCPERP is deemed a swap, Kalshi cannot simply rename its product and continue. The product's entire operational layer — its execution venue, clearing relationship, margin calculations, and reporting obligations — would require significant reconstruction to fit the swap framework. The delay alone could cripple Kalshi's market entry. This possibility is central to the case: CME's argument is not merely semantic pedantry, but a structural claim about how continuous-settlement products must be supervised.

Yet there is a broader, underappreciated issue hiding behind the classification question. Perpetual contracts present a subtle counterparty risk profile that traditional margining may not fully capture. In a traditional future, expiration forces position compression: the exposure exists for a defined period, after which settlement extinguishes it. A perpetual has no natural extinguishing event. Its open interest persists indefinitely, creating a long-tail exposure continuum in which every existing contract remains alive until its owner voluntarily closes it. If the funding rate mechanism fails to properly anchor price — in a flash crash, a liquidity drought, or a squeeze — a no-expiration derivative provides fewer natural circuit breakers than its time-bound counterpart. That is not a technical nuance. It is a systemic risk consideration that affects how regulators should think about margin levels and stress testing for products without tenors.

Liquidity Risks Hidden Inside the Compliance Wrapping

The sustainable operation of any perpetual contract depends absolutely on one thing: sufficient arbitrage capital to enforce convergence through the funding mechanism. In the crypto-native venues where perpetuals first evolved, market makers run sophisticated funding-arbitrage strategies, continuously adjusting to deviations between the perpetual price and its underlying spot index. In a newly approved, cash-settled, CFTC-regulated product offered by a prediction market startup, that arbitrage layer may be thinner — and thinner arbitrage means weaker convergence. When funding rates fail to pull price back to spot, the product deviates from its intended function, exposing both longs and shorts to an unpriced basis distortion.

The CFTC's own approval process, by blessing the product's structure, implicitly assumed that funding mechanics validated in offshore markets will function identically in a thin, retail-weighted, compliant venue. That assumption is unproven. The mechanism may perform flawlessly in deep, professional order books but misbehave in markets where a small group of non-professional holders dominates open interest. This is not a reason to block the product. It is a reminder that classification approval and operational success are entirely different things. Regulators can approve a genre; only liquidity can validate it.

How Kalshi Navigates the Regulatory Ecosystem

Kalshi itself deserves closer examination. Unlike CME — a century-old global infrastructure business with massive trading volumes, deep political relationships, and broad institutional reach — Kalshi is a venture-backed startup best known for event markets in politics and economics. Its position in the crypto derivative world is marginal. Its advantage is precisely the thing CME lacks: regulatory speed and structural hunger. A startup without a legacy product line to protect can reimagine the relationship between crypto-native mechanics and regulated market structure without the institutional drag of existing revenue streams.

CME, by contrast, faces a genuine internal contradiction. Its existing bitcoin futures franchise is built on monthly and quarterly expirations. A perpetual contract would compete with those established products. But that contradiction may be resolved through this litigation: if CME wins its legal argument — if courts clarify that no-expiration contracts are legally distinct — CME can then launch its own perpetual contract, with its own superior liquidity and institutional distribution, using the very regulatory clarity it helped create. Losing this particular lawsuit would expose CME to an era of ambiguous regulatory competition from smaller rivals. Winning the underlying classification debate would let CME enter the perpetual market on its own terms.

The pivot point where genre defines value is rarely visible in the moment. Here it is visible: CME is not trying to make perpetual contracts illegal. It is trying to make perpetual contracts legally legible — legible on terms CME can navigate, with a compliance barrier high enough that only institutions with serious compliance infrastructure can participate. If the market concludes that perpetuals are swaps, small startups without swap execution facilities will struggle to compete. If the market concludes that perpetuals are futures, then CME's scale advantages in the existing futures infrastructure will dominate. Either path leads to CME being able to participate profitably in the next narrative.

Market Climate and Market Psychology

Timing matters here. The litigation emerges in a broader market environment that is still absorbing the shocks of 2022 — collapsed protocols, evaporated liquidity, destroyed counterparties — and transitioning toward an institutional purchase of crypto assets following the approval of spot ETFs. Wholesale crypto market sentiment in the period after Kalshi's approval fluctuated visibly: spot BTC prices swung from about $71,000 in June 2024 down to the low $50,000s in the wake of distribution events tied to Mt. Gox reimbursements and other stale supply, before partially recovering to the $60,000-$66,000 range. Funding rates across dominant crypto-native venues frequently traded negative during the lower range, suggesting speculative fatigue.

In such a market, news about a lawsuit over one particular CFTC product approval is unlikely to trigger a mass price dislocation. Yet sophisticated institutional operators should not mistake low price volatility for low informational value. Speculative noise and structural signal are different quantities. In a bull phase marked by post-ETF institutional convergence, every event that sharpens (or blurs) the boundary around compliant crypto derivative access deserves close reading, even when immediate market reaction is muted.

If anything, the approval of a regulated perpetual suggests the crypto derivative market may be evolving toward a two-tier equilibrium: a vast global offshore perpetual market serving retail and crypto-native professionals, and a narrower onshore compliant market serving institutions that require US-regulated exposure. The CME lawsuit is an attempt to define the onshore tier's architecture. Whatever the outcome, it will likely accelerate the distinction between compliant and non-compliant crypto derivative venues.

A Contrarian Read: Victory for Kalshi Could Open the Door for CME's Dominance

There is an uncomfortable irony that market observers gloss over. If the court denies CME's arguments and confirms BTCPERP as a legitimate futures product, Kalshi wins the case — but the legal victory paves a road that CME, with its capital advantages and operational scale, is best positioned to travel. Should the product classification be settled, CME will likely launch its own regulated perpetual. It may launch one quickly. As the CFTC hinted in its filings, nothing prevents CME from offering a similar product — only its own strategic hesitation does.

Every week of litigation uncertainty hands CME a longer runway to prepare entry. Each legal victory for Kalshi in confirming the category buys time for new, capitalized incumbents to observe the Kalshi experiment, learn from its infrastructure choices, identify its liquidity weaknesses, and build a superior market. The underdog that clears the legal path may find the heaviest freight train following right behind it.

The regulatory framework, if clarified, is a framework for all. Kalshi's first-mover advantage in legal standing evaporates the moment the category is safe. This is the brutal mathematics of institutional adoption: regulatory pioneers provide the clarity, and capital takes the profit. Any investor evaluating Kalshi's trajectory should understand that legal victory is the beginning of Kalshi's real competitive challenge, not the end of it.

What a CFTC Dismissal Would Actually Mean

Should the court grant the CFTC's motion to dismiss, the message to the market is that the regulatory approval pipeline remains intact. Product approvals are presumed valid; competitors may not use litigation to relitigate jurisdictional classifications they could have addressed through the CFTC's own comment processes. That outcome would remove the immediate uncertainty discount applied to Kalshi's future, accelerate its ability to expand its product lineup, and signal to other startups that novel derivative structures can navigate approval without facing litigation gauntlets.

But dismissal also leaves the deeper questions unresolved. It would mean that the no-expiration future's claim to the futures genre rests on a single agency's approval, not on settled statutory interpretation. Every subsequent administration, every new court challenge, every shift in the political winds of the CFTC could revisit the question. Regulatory certainty built on dismissal is still regulatory certainty built on sand.

The alternative path — a court decision on the merits — carries risk for both parties, yet offers the entire industry something dismissal cannot: durable legal clarity. If a court rules that a perpetual contract with funding payments is a valid future, the product genre receives a judicial seal of approval that no future administrative decision can quietly reverse. If the court rules the other way, the market gains absolute definition over the boundary. The outcome that seems dangerous in the short run — a full litigation cycle — may be precisely the clarifying event that institutional capital needs to fully engage.

Structural Verdict and the Institutional Perspective

Stepping back from the legal theater, what stands out is the deeper structural trend beneath this case. The derivatives industry is converging on a single question: what happens to time in a technology-enabled market? Traditional futures assume that counterparties need a settlement moment — a point at which positions end and obligations are discharged. Perpetuals embody a different philosophy: obligations are deliberately continuing, settled economically every few hours through funding payments, but never truly finalized until the user chooses to exit.

This philosophical shift from episodic settlement to continuous settlement parallels the broader shift in financial markets from batch processing to always-on infrastructure. The question of whether such products should be called futures or swaps is simply the legal world's attempt to translate a transformation in market cadence into analog-era categories. This litigation matters because the translation is imperfect and high-stakes.

Whatever the court decides, the underlying demand for perpetual exposure in institutional portfolios is unlikely to fade. ETF-driven bitcoin adoption has produced a wider class of asset holders who increasingly seek sophisticated derivative overlays. Many will inevitably want leveraged exposure without the friction of rolling monthly futures positions. Where the regulated market fails to satisfy that demand, capital flows to offshore venues. The loser of this litigation may thus be the American market itself, in the form of continued migration of derivative activity to jurisdictions with clearer frameworks.

The narrative is moving toward a new genre. The last two years have quietly reconstructed the financial ecosystem into layers: spot ETFs for the least complex investor, traditional futures for institutions, perpetuals for sophisticated professionals, and option structures for everything in between. Future frameworks for the next narrative cycle will likely center continuous-settlement derivative access across jurisdictions and across asset classes.

What I'm Watching: Signals, Not Verdicts

The courtroom outcome itself will be less informative than the market response following it. Three signals matter more than headlines. First, whether CME announces its own bitcoin perpetual product within six months of resolution — regardless of which side wins. That announcement would be CME's confession that perpetuals are part of the relevant futures landscape. Second, whether Kalshi's open interest and daily volume show sustainable institutional participation after the resolution. Regulatory victory without genuine volume would render the product symbolically relevant to the genre but irrelevant to the market. Third, whether the CFTC extends its approval logic to other perpetual variants — ether-perpetuals, index-based perpetuals — which would indicate the era of continuous-settlement futures has truly arrived.

Culture is mimicking utility in this sector. The market no longer asks whether perpetuals should exist; they have generated too much volume and investor usage to be dismissed as offshore anomalies. The remaining question is whether the genre gets defined inside the American regulatory establishment or continues growing in a parallel global market defined primarily by crypto exchanges and their own rule engines.

The Last Word Is a Question

In the end, the plaintiff before the court is CME, but the legal claim being tested is more subtle than the headlines suggest. This is not an incumbent suing a startup over market share. It is an incumbent suing because the regulator redefined the future by permitting the past to vanish. The true dispute is not about what is happening today, but about who will define the next era of institutional crypto derivatives. Building frameworks for the next narrative cycle requires deciding whether perpetual contracts are simply advanced futures that chose to remove death from their lifespan, or a new species that lawyers simply haven't caught up to yet. Ask not whether this product has a future. Ask whether a future without a deadline is still a future — and who gets the authority to answer.